NYSE:RBOT Vicarious Surgical (RBOT) Stock Price, News & Analysis $5.77 -0.19 (-3.19%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$5.43▼$5.8850-Day Range$5.21▼$9.4152-Week Range$4.27▼$29.25Volume14,209 shsAverage Volume27,641 shsMarket Capitalization$33.89 millionP/E RatioN/ADividend YieldN/APrice Target$11.33 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Vicarious Surgical alerts: Email Address Vicarious Surgical MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside96.4% Upside$11.33 Price TargetShort InterestHealthy2.14% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-1.00Based on 4 Articles This WeekInsider TradingSelling Shares$15,903 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($10.07) to ($8.26) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.11 out of 5 starsMedical Sector514th out of 910 stocksSurgical Appliances & Supplies Industry13th out of 18 stocks 3.0 Analyst's Opinion Consensus RatingVicarious Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageVicarious Surgical has only been the subject of 2 research reports in the past 90 days.Read more about Vicarious Surgical's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.14% of the outstanding shares of Vicarious Surgical have been sold short.Short Interest Ratio / Days to CoverVicarious Surgical has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vicarious Surgical has recently increased by 46.61%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldVicarious Surgical does not currently pay a dividend.Dividend GrowthVicarious Surgical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RBOT. Previous Next 1.1 News and Social Media Coverage News SentimentVicarious Surgical has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Vicarious Surgical this week, compared to 1 article on an average week.Search Interest3 people have searched for RBOT on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Vicarious Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,903.00 in company stock.Percentage Held by Insiders11.73% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions47.27% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Vicarious Surgical's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Vicarious Surgical are expected to grow in the coming year, from ($10.07) to ($8.26) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Vicarious Surgical is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vicarious Surgical is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVicarious Surgical has a P/B Ratio of 0.47. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Vicarious Surgical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad True Gold RepublicChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… . Click here now to get your free 'De-Dollarization' Guide. About Vicarious Surgical Stock (NYSE:RBOT)Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Read More RBOT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RBOT Stock News HeadlinesAugust 29, 2024 | americanbankingnews.comShort Interest in Vicarious Surgical Inc (NYSE:RBOT) Grows By 46.6%August 29, 2024 | msn.comVicarious Surgical Inc. (RBOT): Among The Best Medical AI CompaniesSeptember 7, 2024 | Sasco Gold LLC (Ad)Say Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... August 21, 2024 | finance.yahoo.comVicarious Surgical to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceAugust 15, 2024 | venturebeat.comCaresyntax secures $180M to build AI-powered ‘Android of robotic surgery’August 13, 2024 | yahoo.comNew robotic tool expands surgery access in Central ValleyAugust 13, 2024 | msn.comVicarious Surgical Inc. (NYSE:RBOT) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | msn.com‘Almost an immediate change': Robotic surgery offers relief for enlarged prostate patientsSeptember 7, 2024 | Sasco Gold LLC (Ad)Say Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late... August 13, 2024 | seekingalpha.comVicarious Surgical Inc (RBOT) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | investorplace.comRBOT Stock Earnings: Vicarious Surgical Misses EPS for Q2 2024August 12, 2024 | finance.yahoo.comVicarious Surgical Reports Second Quarter 2024 Financial ResultsAugust 7, 2024 | stockhouse.comVicarious Surgical Announces New Hospital System Partnership with LSU Health New OrleansJuly 25, 2024 | msn.comUPHS-Marquette celebrates milestone use of robotic surgery deviceJuly 25, 2024 | msn.comModesto hospital rolls out robotic-assisted surgery for heart patients. What makes it better?June 10, 2024 | businesswire.comVicarious Surgical Announces Reverse Stock SplitMay 29, 2024 | msn.comResearch shows robotic ultrasound systems can aid doctors during surgeryMay 3, 2024 | yahoo.comRevolutionizing surgery: Tacoma hospital unveils state-of-the-art surgical robotSee More Headlines Receive RBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/12/2024Today9/07/2024Next Earnings (Estimated)11/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNYSE:RBOT CUSIPN/A CIK1812173 Webwww.vicarioussurgical.com Phone617 868 1700FaxN/AEmployees3Year FoundedN/APrice Target and Rating Average Stock Price Target$11.33 High Stock Price Target$12.00 Low Stock Price Target$10.00 Potential Upside/Downside+97.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($11.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-71,070,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-74.02% Return on Assets-59.42% Debt Debt-to-Equity RatioN/A Current Ratio10.57 Quick Ratio10.57 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$12.19 per share Price / Book0.47Miscellaneous Outstanding Shares5,873,000Free Float5,184,000Market Cap$33.71 million OptionableOptionable Beta1.12 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key CompetitorsMilestone ScientificNYSE:MLSSAlpha Pro TechNYSE:APTEnvoy MedicalNASDAQ:COCHCollPlant BiotechnologiesNASDAQ:CLGNNutribandNASDAQ:NTRBView All CompetitorsInsiders & InstitutionsAdam David SachsSold 396 sharesTotal: $2,328.48 ($5.88/share)Sammy KhalifaSold 204 sharesTotal: $1,199.52 ($5.88/share)William John KellySold 186 sharesTotal: $1,078.80 ($5.80/share)John MazzolaSold 195 sharesTotal: $1,134.90 ($5.82/share)Adam David SachsSold 698 sharesTotal: $4,411.36 ($6.32/share)View All Insider TransactionsView All Institutional Transactions RBOT Stock Analysis - Frequently Asked Questions How have RBOT shares performed this year? Vicarious Surgical's stock was trading at $11.0010 at the beginning of 2024. Since then, RBOT stock has decreased by 47.6% and is now trading at $5.77. View the best growth stocks for 2024 here. How were Vicarious Surgical's earnings last quarter? Vicarious Surgical Inc (NYSE:RBOT) announced its earnings results on Monday, August, 12th. The company reported ($2.86) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.98) by $0.12. When did Vicarious Surgical's stock split? Vicarious Surgical shares reverse split before market open on Thursday, June 13th 2024. The 1-30 reverse split was announced on Thursday, June 13th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. Who are Vicarious Surgical's major shareholders? Vicarious Surgical's top institutional investors include DDD Partners LLC (4.21%). Insiders that own company stock include Ventures V LP Khosla, Adam David Sachs, Sammy Khalifa, June Morris, William John Kelly, John Mazzola and Philip Liang. View institutional ownership trends. How do I buy shares of Vicarious Surgical? Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:RBOT) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vicarious Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RBOT Stock Alerts